Ackermans & van Haaren is a venture capital fund focusing on series B investments in the biotech and pharma sectors, with investment amounts between $250k and $5M. It is part of a larger group involved in marine engineering, private banking, real estate, and energy, and is listed on the BEL20 index in Brussels. Notable investments include Vico Therapeutics. The fund targets strategic participations with high growth potential.
